Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Real-world clinical characteristics and treatment patterns among people with hepatocellular carcinoma in the United States (US) treated with resection or ablation.
Authors
Neehar Parikh
University of Michigan, Ann Arbor, MI
Neehar Parikh , Dex L. Underwood , Jenny Hu , Heide A. Stirnadel-Farrant , Nehemiah Kebede , Ravi Patel , Kirema Garcia-Reyes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 436)
DOI
10.1200/JCO.2024.42.3_suppl.436
Abstract #
436
Poster Bd #
A1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Number of subsequent treatments and time to recurrence in hepatocellular carcinoma.
First Author: Juan Jose Juarez
Poster
2024 ASCO Breakthrough
Non-invasive minimal residual disease detection of liver cancer using circulating tumor DNA features and α-fetoprotein: A prospective study.
First Author: Yinyin Chang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.
First Author: Stephen Chan
Poster
2023 ASCO Genitourinary Cancers Symposium
Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021.
First Author: John McGrane